The detection of p53 gene mutation using a microdissection technique in primary intracranial germ cell tumors

被引:1
作者
Kim, SK
Cho, BK
Paek, SH
Hong, SJ
Kim, HS
Hong, SY
Choe, G
Chi, JG
Nam, DH
Wang, KC
机构
[1] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea
[2] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea
[3] Seoul Natl Univ Hosp, Lab Fetal Med Res, Clin Res Inst, Seoul 110744, South Korea
[4] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea
关键词
germ cell tumor; p53 gene mutation; microdissection; dideoxyfingerprinting; outcome;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using a microdissection technique, the contribution of the p53 mutation to tumorigenesis and prognosis in each histological subtype of the intracranial germ cell tumors (GCTs) was evaluated. Nineteen patients had primary intracranial GCTs, including 4 germinomas (GEs), 4 teratomas (TEs), 1 mixed tumor of GE and TE, and 10 mixed GCTs containing non-germinomatous malignant germ cell tumors (NG-MGCTs). After microdissection of specific subtypes, genomic DNA was screened for mutations in exons 5-8 of the p53 gene, using the dideoxyfingerprinting (ddF) followed by direct DNA sequencing. The direct sequencing revealed a total of six mutations in PCR products derived from the five cases (26%) which showed mobility shifts in ddF. Among the six mutations detected, four were missense mutations and two were silent. Missense mutations of the p53 gene tended to occur more frequently in the NG-MGCT component than in the GE or TE components (3/15; vs. 1/12 vs. 0/13). The incidence of missense mutations was not different between the survivors (3/13) and the deceased (1/6). This study suggests the possible role of the p53 gene in the tumori-genesis of NG-MGCT. However, p53 gene mutation did not correlate with the prognosis of NG-MGCT.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 35 条
[1]  
AHOMADEGBE JC, 1995, ONCOGENE, V10, P1217
[2]   A COMPARATIVE MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF TESTICULAR SEMINOMAS AND INTRACRANIAL GERMINOMAS [J].
BENTLEY, AJ ;
PARKINSON, MC ;
HARDING, BN ;
BAINS, RM ;
LANTOS, PL .
HISTOPATHOLOGY, 1990, 17 (05) :443-449
[3]  
BRACHMAN DG, 1993, CANCER RES, V53, P3667
[4]   INTRACRANIAL GERM-CELL TUMORS - DETECTION OF P53 GENE-MUTATIONS BY SINGLE-STRAND CONFORMATION POLYMORPHISM ANALYSIS [J].
FENG, XL ;
ZHANG, SJ ;
ICHIKAWA, T ;
KOGA, H ;
WASHIYAMA, K ;
MOTOYAMA, T ;
KUMANISHI, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (06) :555-561
[5]  
FRANKEL RH, 1992, CANCER RES, V52, P1427
[6]  
Guillou L, 1996, AM J PATHOL, V149, P1221
[7]   CLINICAL IMPLICATIONS OF THE P53 TUMOR-SUPPRESSOR GENE [J].
HARRIS, CC ;
HOLLSTEIN, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (18) :1318-1327
[8]   HOW SENSITIVE IS PCR-SSCP [J].
HAYASHI, K ;
YANDELL, DW .
HUMAN MUTATION, 1993, 2 (05) :338-346
[9]   NO GERMLINE TP53 MUTATIONS DETECTED IN FAMILIAL AND BILATERAL TESTICULAR CANCER [J].
HEIMDAL, K ;
LOTHE, RA ;
LYSTAD, S ;
HOLM, R ;
FOSSA, SD ;
BORRESEN, AL .
GENES CHROMOSOMES & CANCER, 1993, 6 (02) :92-97
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53